jRCT2080223007未知3 期
Efficacy and safety trial of AJG533 with long term treatment in patients with chronic constipation
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 360
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Open labeled, Multicenter
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- All
入选标准
- •<Main inclusion criteria>
- •Patients with chronic constipation
排除标准
- •<Main exclusion criteria>
- •Patients with known or suspected organic constipation
- •Patients with known or suspected symptomatic constipation or drug-induced constipation
结局指标
主要结局
-
Adverse Event
次要结局
未报告次要终点
研究者
相似试验
已完成
3 期
Phase 3 study of AJG555 in patients with chronic constipationChronic constipationjRCT2080223112EA Pharma Co., Ltd.140
未知
3 期
Phase III study of AJG511 in patients with active ulcerative colitisulcerative colitisJPRN-jRCT2080222653EA Pharma Co.,Ltd.120
未知
3 期
Phase 3 study of AJG533 in patients with chronic constipatioChronic constipationJPRN-jRCT2080223008EA Pharma Co.,Ltd.120
已完成
3 期
Phase III study of AJM300 in patients with active ulcerative colitis (2)jRCT2080223867EA Pharma Co., Ltd.198
已完成
3 期
Phase III study of AJM300 in patients with active ulcerative colitis (2)Active Ulcerative ColitisJPRN-jRCT2080223867EA Pharma Co., Ltd.198